📰 Post Dose News
Post Dose News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Post Dose. Real-time updates on events, politics, business and more.
April 12, 2023
Aeglea BioTherapeutics Announces Interim Results from Ongoing Phase 1/2 Clinical Trial of Pegtarviliase for the Treatment of Classical Homocystinuria and Begins Process to... | April 12, 2023
April 12, 2023
Results from Cohorts 1 and 2 Showed a Dose-Dependent Reduction in Total Homocysteine Levels Results from Cohort 3 Indicated Additional Dose Exploration and Data from Longer Treatment Duration May... | April 12, 2023